FDA Approved: SCEMBLIX — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved SCEMBLIX (asciminib) from Novartis as an original approval for chronic myeloid leukemia. It represents a first-in-class targeted therapy for pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• SCEMBLIX (ASCIMINIB)

Snippet

ORIG AP for SCEMBLIX (ASCIMINIB)